Bruush Oral Care Inc. reported in a Form 6-K filing with the SEC that it is currently non-compliant with Nasdaq's audit committee requirements following the resignation of a board member from its Audit Committee on April 12, 2023. The company was given until April 12, 2024, to regain compliance but failed to do so. Kia Besharat resigned as chair and member of the Audit Committee on April 10, 2024, due to not meeting the independence requirements, though he remains an independent director on the board. Bruush Oral Care has requested a hearing with the Nasdaq Hearings Panel to appeal the delisting of its securities, which is scheduled for April 25, 2024. The company received a notice on April 15, 2024, stating that its non-compliance is an additional basis for delisting from the Nasdaq Stock Market. The company has submitted a compliance plan to the Panel, but there is no assurance regarding the Panel's decision.

Bruush Oral Care Inc. reported in a Form 6-K filing with the SEC that it is currently non-compliant with Nasdaq's audit committee requirements following the resignation of a board member from its Audit Committee on April 12, 2023. The company was given until April 12, 2024, to regain compliance but failed to do so. Kia Besharat resigned as chair and member of the Audit Committee on April 10, 2024, due to not meeting the independence requirements, though he remains an independent director on the board. Bruush Oral Care has requested a hearing with the Nasdaq Hearings Panel to appeal the delisting of its securities, which is scheduled for April 25, 2024. The company received a notice on April 15, 2024, stating that its non-compliance is an additional basis for delisting from the Nasdaq Stock Market. The company has submitted a compliance plan to the Panel, but there is no assurance regarding the Panel's decision.